Hoekstra Menno, Zhang Zhengzheng, Lindenburg Peter W, Van Eck Miranda
Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Pharmacy Leiden, Leiden, The Netherlands.
J Lipid Atheroscler. 2024 Jan;13(1):69-79. doi: 10.12997/jla.2024.13.1.69. Epub 2023 Nov 6.
Scavenger receptor class B type I (SR-BI) is primarily known for its role in the selective uptake of cholesteryl esters (CEs) from high-density lipoproteins (HDLs). Here we investigated whether SR-BI deficiency is associated with other potentially relevant changes in the plasma lipidome than the established effect of HDL-cholesterol elevation.
Targeted ultra-high-performance liquid chromatography-tandem mass spectrometry was utilized to measure lipid species in plasma from female wild-type and SR-BI knockout mice.
SR-BI deficiency was associated with a reduction in the average CE fatty acid length (-2%; <0.001) and degree of CE fatty acid unsaturation (-18%; <0.001) due to a relative shift from longer, polyunsaturated CE species CE (20:4), CE (20:5), and CE (22:6) towards the mono-unsaturated CE (18:1) species. Sphingomyelin (SM) levels were 64% higher (<0.001) in SR-BI knockout mice without a parallel change in (lyso)phosphatidylcholine (LPC) concentrations, resulting in an increase in the SM/LPC ratio from 0.102±0.005 to 0.163±0.003 (<0.001). In addition, lower LPC lengths (-5%; <0.05) and fatty acid unsaturation degrees (-20%; <0.01) were detected in SR-BI knockout mice. Furthermore, SR-BI deficiency was associated with a 4.7-fold increase (<0.001) in total plasma ceramide (Cer) levels, with a marked >9-fold rise (<0.001) in Cer (d18:1/24:1) concentrations.
We have shown that SR-BI deficiency in mice not only impacts the CE concentrations, length, and saturation index within the plasma compartment, but is also associated with plasma accumulation of several Cer and SM species that may contribute to the development of specific hematological and metabolic (disease) phenotypes previously detected in SR-BI knockout mice.
I 型 B 类清道夫受体(SR-BI)主要因其在从高密度脂蛋白(HDL)中选择性摄取胆固醇酯(CE)方面的作用而闻名。在此,我们研究了 SR-BI 缺乏是否与血浆脂质组中其他潜在相关变化有关,而非已确定的 HDL 胆固醇升高的影响。
采用靶向超高效液相色谱-串联质谱法测量雌性野生型和 SR-BI 基因敲除小鼠血浆中的脂质种类。
由于从较长的多不饱和 CE 种类 CE(20:4)、CE(20:5)和 CE(22:6)向单不饱和 CE(18:1)种类的相对转变,SR-BI 缺乏与平均 CE 脂肪酸长度降低(-2%;<0.001)和 CE 脂肪酸不饱和度降低(-18%;<0.001)有关。SR-BI 基因敲除小鼠的鞘磷脂(SM)水平高出 64%(<0.001),而(溶血)磷脂酰胆碱(LPC)浓度没有平行变化,导致 SM/LPC 比值从 0.102±0.005 增加到 0.163±0.003(<0.001)。此外,在 SR-BI 基因敲除小鼠中检测到较短的 LPC 长度(-5%;<0.05)和较低的脂肪酸不饱和度(-20%;<0.01)。此外,SR-BI 缺乏与血浆总神经酰胺(Cer)水平增加 4.7 倍(<0.001)有关,Cer(d18:1/24:1)浓度显著升高超过 9 倍(<0.001)。
我们已经表明,小鼠中的 SR-BI 缺乏不仅影响血浆中 CE 的浓度、长度和饱和度指数,还与几种 Cer 和 SM 种类的血浆蓄积有关,这可能有助于先前在 SR-BI 基因敲除小鼠中检测到的特定血液学和代谢(疾病)表型的发展。